Skip to main content
Tuesday, September 8, 2026
BTC $78,377 ▼ 1.24%
GOKHSHTEIN
.
Live Wire
Politics
World
Markets
Digital Assets
Technology
Sports
Sections
Franchises
The Brief
The Big Read
The Breakdown
Crypto Culture
More Sections
DeFi & On-Chain
U.S. Equities
Macro & Rates
Research
Subscribe
Menu
×
News
Live Wire
Politics
World
Markets
Digital Assets
Technology
Sports
Franchises
The Brief
The Big Read
The Breakdown
Crypto Culture
More
DeFi & On-Chain
U.S. Equities
Macro & Rates
Research
Subscribe
LIVE
BTC
$78,377
down
−1.24%
ETH
$2,480
down
−0.63%
SOL
$103.06
down
−1.23%
XRP
$1.42
up
+1.38%
LINK
$12.55
down
−2.18%
ADA
$0.220
down
−0.25%
S&P 500
7,674
down
−0.58%
Nasdaq
26,421
down
−0.32%
Dow
52,788
down
−1.17%
RUT
2,967
down
−0.30%
TNX
4.81%
up
+0.46%
TYX
5.26%
up
+0.34%
FVX
4.57%
up
+0.51%
IRX
3.77%
up
+0.48%
VIX
15.52
up
+6.81%
GOLD
$4,407.00
down
−1.55%
SILVER
$66.35
down
−0.60%
OIL
$93.68
up
+2.40%
DXY
98.86
down
−0.32%
NVDA
$225.73
down
−2.01%
AAPL
$316.22
down
−1.17%
TSLA
$368.16
up
+3.98%
META
$613.48
down
−0.53%
MSFT
$493.95
down
−1.15%
AMZN
$256.97
down
−0.60%
GOOGL
$338.36
down
−0.03%
Fear & Greed
69 — Greed
BTC
$78,377
down
−1.24%
ETH
$2,480
down
−0.63%
SOL
$103.06
down
−1.23%
XRP
$1.42
up
+1.38%
LINK
$12.55
down
−2.18%
ADA
$0.220
down
−0.25%
S&P 500
7,674
down
−0.58%
Nasdaq
26,421
down
−0.32%
Dow
52,788
down
−1.17%
RUT
2,967
down
−0.30%
TNX
4.81%
up
+0.46%
TYX
5.26%
up
+0.34%
FVX
4.57%
up
+0.51%
IRX
3.77%
up
+0.48%
VIX
15.52
up
+6.81%
GOLD
$4,407.00
down
−1.55%
SILVER
$66.35
down
−0.60%
OIL
$93.68
up
+2.40%
DXY
98.86
down
−0.32%
NVDA
$225.73
down
−2.01%
AAPL
$316.22
down
−1.17%
TSLA
$368.16
up
+3.98%
META
$613.48
down
−0.53%
MSFT
$493.95
down
−1.15%
AMZN
$256.97
down
−0.60%
GOOGL
$338.36
down
−0.03%
Fear & Greed
69 — Greed
Tag
intismeran
1 article
Research & Analysis
20d ago
Merck, Moderna's mRNA Melanoma Vaccine Succeeds in Phase 3 Trial
Intismeran, combined with Keytruda, reduced melanoma recurrence—the first neoantigen vaccine to clear a late-stage randomized trial.